Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-13 5:06 pm Sale | 13G | HALOZYME THERAPEUTICS INC HTI | VANGUARD GROUP INC | 13,259,514 10.04% | -269,116 (-1.99%) | View |
2024-02-12 06:19 am Sale | 13G | HALOZYME THERAPEUTICS INC HTI | Artisan Partners Limited Partnership | 6,689,058 5.1% | -451,895 (-6.33%) | View |
2024-02-01 3:51 pm Sale | 13G | HALOZYME THERAPEUTICS INC HTI | Invesco Ltd. IVZ | 2,816,427 2.1% | -4,220,524 (-59.98%) | View |
2024-01-23 11:52 am Sale | 13G | HALOZYME THERAPEUTICS INC HTI | BlackRock Inc. BLK | 18,629,818 14.1% | -566,243 (-2.95%) | View |
2023-06-09 2:15 pm Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | VANGUARD GROUP INC | 13,528,630 10.27% | 224,783 (+1.69%) | View |
2023-02-10 2:11 pm Unchanged | 13G | HALOZYME THERAPEUTICS INC HTI | BlackRock Inc. BLK | 19,196,061 14.2% | 0 (Unchanged) | View |
2023-02-10 09:00 am Sale | 13G | HALOZYME THERAPEUTICS INC HTI | Artisan Partners Limited Partnership | 7,140,953 5.3% | -2,364,815 (-24.88%) | View |
2023-02-09 6:35 pm Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | Invesco Ltd. IVZ | 7,036,951 5.2% | 7,036,951 (New Position) | View |
2023-02-09 11:22 am Sale | 13G | HALOZYME THERAPEUTICS INC HTI | VANGUARD GROUP INC | 13,303,847 9.84% | -238,742 (-1.76%) | View |
2023-01-26 08:52 am Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | BlackRock Inc. BLK | 19,196,061 13.6% | 981,990 (+5.39%) | View |
2023-01-20 3:00 pm Sale | 13G | HALOZYME THERAPEUTICS INC HTI | BlackRock Inc. BLK | 18,214,071 13.6% | -1,225,792 (-6.31%) | View |
2022-12-12 3:09 pm Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | VANGUARD GROUP INC | 13,542,589 10.02% | 46,676 (+0.35%) | View |
2022-02-10 08:17 am Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | VANGUARD GROUP INC | 13,495,913 9.59% | 346,210 (+2.63%) | View |
2022-02-04 06:15 am Sale | 13G | HALOZYME THERAPEUTICS INC HTI | Artisan Partners Limited Partnership | 9,505,768 6.8% | -778,368 (-7.57%) | View |
2022-01-28 1:54 pm Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | BlackRock Inc. BLK | 19,439,863 13.8% | 958,556 (+5.19%) | View |
2021-02-12 5:01 pm Sale | 13G | HALOZYME THERAPEUTICS INC HTI | BB BIOTECH AG | 3,970,000 2.9% | -3,993,056 (-50.14%) | View |
2021-02-10 10:57 am Sale | 13G | HALOZYME THERAPEUTICS INC HTI | VANGUARD GROUP INC | 13,149,703 9.73% | -873,756 (-6.23%) | View |
2021-02-10 06:17 am Sale | 13G | HALOZYME THERAPEUTICS INC HTI | Artisan Partners Limited Partnership | 10,284,136 7.6% | -4,145,901 (-28.73%) | View |
2021-01-26 2:22 pm Sale | 13G | HALOZYME THERAPEUTICS INC HTI | BlackRock Inc. BLK | 18,481,307 13.7% | -202,823 (-1.09%) | View |
2020-12-08 4:56 pm Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | BlackRock Inc. BLK | 18,684,130 13.8% | 6,587,333 (+54.46%) | View |